Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Shares Out (Diluted) Over TimeStrong
Percentile Rank100
3Y CAGR+12.4%
5Y CAGR+17.5%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+12.4%/yr
vs +45.6%/yr prior
5Y CAGR
+17.5%/yr
Recent deceleration
Acceleration
-33.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 66500000.00 | +3.3% |
| 2024 | 64395000.00 | +32.9% |
| 2023 | 48449000.00 | +3.3% |
| 2022 | 46888000.00 | +9.4% |
| 2021 | 42870000.00 | +44.6% |
| 2020 | 29640000.00 | +104.3% |
| 2019 | 14507000.00 | +38.9% |
| 2018 | 10442000.00 | +21.8% |
| 2017 | 8570000.00 | +26.6% |
| 2016 | 6768633.00 | - |